BrainParrot

BRIC’s third Foundation Day celebrated at NII

GS3Full notePublished: · Updated:

Source: PIB (Press Information Bureau) · Read the original ↗

Summary

  • The Biotechnology Research and Innovation Council (BRIC) marked its third Foundation Day at BRIC–National Institute of Immunology (NII).
  • Dr Jitendra Singh, MoS (IC) for Science & Technology, said India has the potential to lead a biotechnology-driven industrial revolution. He called for deeper integration across science institutions and more industry participation.
  • The event also saw the Wellcome Trust announce a PhD training grant and BRIC sign a Letter of Intent with the UK's Centre for Process Innovation (CPI) on biomanufacturing.

UPSC relevance: GS3 — S&T (biotechnology, research governance, bioeconomy)

Key facts for Prelims

  • BRIC: apex autonomous body (registered Society) under DBT, Ministry of Science & Technology, formed by subsuming DBT's autonomous institutions. The article gives 13 institutions across 11 cities.
  • iBRIC+ = BRIC institutes + RCB (Faridabad) + ICGEB.
  • DBT is the nodal department for biotechnology. BIRAC is the DBT-linked entity for biotech entrepreneurship and innovation. The article names BIRAC, the Research, Development and Innovation (RDI) Fund and the Anusandhan National Research Foundation (ANRF) as parts of the research and innovation landscape.
  • Biofoundry hubs named in the article: Mohali, Hyderabad, Pune, Thiruvananthapuram.
  • i3C PhD programme (i3C = ideate, immerse, innovate, collaborate). The article mentions placements in the health and agriculture sectors.
  • BRIC–NII, the host institute, is in New Delhi (Director: Dr Pushkar Sharma).
  • Genomics Centre of Excellence: linked to precision medicine; AIIMS and other medical institutions have shown interest.
  • PM-STIAC (Prime Minister's Science, Technology and Innovation Advisory Council): Lt. Gen. (Retd.) Dr Madhuri Kanitkar attended as a member.
  • Background not confirmed from a trusted source: ANRF's statutory details and the RDI Fund's size.

Data and details

  • Bioeconomy: about USD 10 billion when the Government took office → more than USD 195 billion (minister's claim).
  • Biotech startups: about 50–60 → more than 11,000.
  • i3C PhD programme: nearly 200 students have benefited.
  • Wellcome Trust: grant of up to ₹21.7 crore for a five-year immersion training programme for more than 250 iBRIC+ PhD scholars.
  • Letter of Intent between BRIC and UK's Centre for Process Innovation (CPI): India–UK collaboration on biomanufacturing and development of biofoundries.
  • BRIC network: 13 institutions across 11 cities, a decentralised network (DG BRIC).
  • DG BRIC's four pillars: people, culture, trust, resource allocation.
  • Other BRIC programmes: BRIC–BIRAC entrepreneurship programmes.
  • Minister's claim: the "joint family" model reduced delays from multiple directorates and approvals, and other departments and ministries have replicated it.
  • Minister's stated direction: private-sector participation in science drawing on nuclear-sector reforms; biomanufacturing hubs, biofoundries and AI-integrated biomanufacturing.
  • Minister's vision: the next industrial revolution driven by biotechnology, AI and genomics, with India at the centre rather than adopting it later, unlike earlier revolutions.
  • PM's Independence Day appeal to youth on biotechnology; school and public outreach; minister recalled proposing a dedicated mentorship programme for girls in science.
  • Awards: iBRIC+ Spotlight Scientist of the Year–2026 to Dr Sunil Laxman (BRIC-inStem), Dr Rashna Bhandari (BRIC-CDFD) and Prof. Bhabatosh Das (BRIC-THSTI). Winners of the "Festival of Sports" were also felicitated.
  • Also present: Ms Ekta Vishnoi (IRS), Joint Secretary (Administration), DBT.

Static–dynamic linkage

The news is an instance of consolidating public-funded research institutions to cut silos, reduce procedural delay and speed up translation from lab to market. The static ideas behind it are:

  • Autonomous bodies registered as societies under a parent department.
  • The Department of Biotechnology (DBT) as nodal department for biotech promotion.
  • The bioeconomy as a pillar of self-reliance (Atmanirbhar Bharat).
  • Public–private partnership in research.
  • Biomanufacturing and biofoundries as the shift from "discovery" to "production" in biotech.

Syllabus mapping: GS3 – S&T: Indigenisation of technology, biotechnology and its applications; GS3 – Economy: Mobilisation of resources, industrial policy; GS2 – Governance: institutional reform and rationalisation of autonomous bodies.

Background primer

Biotechnology Research and Innovation Council (BRIC)

What it is:
An autonomous body (a registered Society) created by the Department of Biotechnology, Ministry of Science and Technology, with Cabinet approval, by subsuming its autonomous institutions.
Founded:
Registered as a Society on 10 November 2023 after Cabinet approval, hence the third Foundation Day in Nov 2026. It followed a Department of Expenditure directive on rationalisation of autonomous bodies.

Additional context

  • BioE3 link: The Union Cabinet approved the BioE3 (Biotechnology for Economy, Environment and Employment) Policy in 2024, to foster high-performance biomanufacturing.
  • Scheme architecture: From FY2024-25 Q4, DBT merged its two earlier schemes (BRD and IED) into one scheme, BioRIDE (Biotechnology Research Innovation and Entrepreneurship Development). Its three components are Biotechnology R&D, Industrial & Entrepreneurship Development, and a new Biomanufacturing and Biofoundry component.
  • i3c PhD programme: Built on the principles "ideate, immerse, innovate, collaborate" (i3c). It is open to Master's graduates in life sciences, B.Tech/BE graduates in non-biological sciences, and medicine graduates.
  • Funding: DBT gives core funding (salaries, infrastructure, intramural research) to the iBRIC+ institutions and three PSUs.
  • Oversight: A first meeting of the BRIC Research Advisory Board was reported in March 2026. The Board guides, reviews and monitors BRIC institutes' research and helps develop new missions.

Mains dimensions

  • Institutional reform:
  • Merging separate autonomous institutes under one society addresses silos, duplicate approvals and uneven cadres. The minister says the model has been replicated by other departments.
  • The DG's vision is to move "beyond isolated institutional excellence" to a networked system.
  • Risk: centralised governance versus the scientific autonomy of individual institutes. This is why the "joint family… retaining identity and autonomy" framing is stressed.
  • Economic dimension: The bioeconomy (USD 10 bn → >195 bn) and the startup base (50–60 → 11,000+) are cited as evidence of momentum. Biomanufacturing (biofoundries, AI-integrated manufacturing) targets value addition beyond R&D and supports sovereign technologies, food security and health security.
  • Translation gap: BRIC–BIRAC entrepreneurship programmes and the lab-to-market goal address India's weak research-to-commercialisation pipeline. Private participation is to be widened on the nuclear-sector model, through the RDI Fund, ANRF and BIRAC.
  • Human capital: The i3C PhD curriculum with placements in health and agriculture, the Wellcome-funded immersion training (>250 scholars) and the girls' mentorship proposal link biotech to skilling and gender inclusion in STEM.
  • International partnerships: The BRIC–CPI LoI and Wellcome funding show the India–UK science and technology axis and the role of philanthropic funding in Indian research.
  • Genomics and precision medicine: The Genomics Centre of Excellence and AIIMS interest point to health-system uptake. Concerns to weigh: data governance, equity of access and ethics.
  • Caution: Headline figures (bioeconomy size, startup counts) are ministerial claims; an answer should present them as official estimates.

Possible Mains question

**GS3, 15 marks:** "Consolidating autonomous research institutions under a single umbrella body can accelerate India's bioeconomy but risks diluting institutional autonomy. Examine with reference to the Biotechnology Research and Innovation Council (BRIC)."

Related topics

  • BioE3 Policy; BioRIDE scheme; BIRAC
  • Anusandhan National Research Foundation; RDI Fund; PM-STIAC
  • Genome India Project / genomics and precision medicine
  • Biomanufacturing and biofoundries; India's bioeconomy
  • India–UK science and technology cooperation

Topics: GS3

How we write and check these notes →

All current affairs of 10 November 2026 → · UPSC Current Affairs